{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T19:23:16Z","timestamp":1774898596953,"version":"3.50.1"},"reference-count":357,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Guru Gobind Singh Indraprastha University"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.ejmech.2019.05.043","type":"journal-article","created":{"date-parts":[[2019,6,24]],"date-time":"2019-06-24T16:36:13Z","timestamp":1561394173000},"page":"111353","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"special_numbering":"C","title":["New dimensions in the field of antimalarial research against malaria resurgence"],"prefix":"10.1016","volume":"181","author":[{"given":"Anudeep K.","family":"Narula","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chandra S.","family":"Azad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lalit M.","family":"Nainwal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2019.05.043_bib1","doi-asserted-by":"crossref","unstructured":"M.E. Wilson, A. Kantele, T.S. Jokiranta. Review of cases with the emerging fifth human malaria parasite Plasmodium knowlesi. Clin. Infect. Dis., 52 (20110, pp. 1356-1362. https:\/\/doi:10.1093\/cid\/cir180.","DOI":"10.1093\/cid\/cir180"},{"key":"10.1016\/j.ejmech.2019.05.043_bib2","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1038\/nrmicro3138","article-title":"Antimalarial drug discovery [mdash] approaches and progress towards new medicines","volume":"11","author":"Flannery","year":"2013","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.ejmech.2019.05.043_bib3","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1002\/9781118493816.ch14","article-title":"Antimalarial drug resistance","author":"Shah","year":"2016","journal-title":"Adv. Malaria Res."},{"key":"10.1016\/j.ejmech.2019.05.043_bib4","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.pt.2016.05.010","article-title":"Artemisinin action and resistance in Plasmodium falciparum","volume":"32","author":"Tilley","year":"2016","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.ejmech.2019.05.043_bib5","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1016\/j.drudis.2015.06.009","article-title":"Supporting malaria elimination with 21st century antimalarial agent drug discovery","volume":"20","author":"Diagana","year":"2015","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ejmech.2019.05.043_bib6","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S1473-3099(02)00239-6","article-title":"Epidemiology of drug-resistant malaria","volume":"2","author":"Wongsrichanalai","year":"2002","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.ejmech.2019.05.043_bib7","series-title":"Emergency Response to Artemisinin Resistance in the Greater Mekong Subregion: Regional Framework for Action (2013-2015)","author":"WHO","year":"2013"},{"key":"10.1016\/j.ejmech.2019.05.043_bib8","series-title":"World Malaria Report-2016","author":"World Health Organization. WHO","year":"2017"},{"key":"10.1016\/j.ejmech.2019.05.043_bib9","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1136\/bmj.1.5851.458","article-title":"Amodiaquine-induced agranulocytosis: toxic effect of amodiaquine in bone marrow cultures in\u00a0vitro","volume":"1","author":"Lind","year":"1973","journal-title":"Br. Med. J."},{"key":"10.1016\/j.ejmech.2019.05.043_bib10","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S0140-6736(84)90410-0","article-title":"Effectiveness of amodiaquine as treatment for chloroquine-resistant Plasmodium falciparum infections in Kenya","volume":"323","author":"Watkins","year":"1984","journal-title":"The Lancet"},{"key":"10.1016\/j.ejmech.2019.05.043_bib11","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1136\/bmj.292.6522.721","article-title":"Amodiaquine induced agranulocytosis and liver damage","volume":"292","author":"Neftel","year":"1986","journal-title":"Br. Med. J."},{"key":"10.1016\/j.ejmech.2019.05.043_bib12","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/S0140-6736(86)92371-8","article-title":"Frequency of severe neutropenia associated with amodiaquine prophylaxis against malaria","volume":"327","author":"Hatton","year":"1986","journal-title":"The Lancet"},{"key":"10.1016\/j.ejmech.2019.05.043_bib13","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/S1473-3099(09)70320-2","article-title":"Pharmacogenetics of antimalarial drugs: effect on metabolism and transport","volume":"9","author":"Kerb","year":"2009","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.ejmech.2019.05.043_bib14","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1124\/dmd.108.025171","article-title":"Novel metabolites of amodiaquine formed by CYP1A1 and CYP1B1: structure elucidation using electrochemistry, mass spectrometry, and NMR","volume":"37","author":"Johansson","year":"2009","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ejmech.2019.05.043_bib15","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1016\/0006-2952(95)00236-S","article-title":"The bioactivation of amodiaquine by human polymorphonuclear leucocytes in\u00a0vitro: chemical mechanisms and the effects of fluorine substitution","volume":"50","author":"Tingle","year":"1995","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejmech.2019.05.043_bib16","doi-asserted-by":"crossref","first-page":"4933","DOI":"10.1021\/jm030796n","article-title":"Isoquine and related amodiaquine Analogues:\u2009 a new generation of improved 4-aminoquinoline antimalarials","volume":"46","author":"O'Neill","year":"2003","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2019.05.043_bib17","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1021\/jm8012757","article-title":"Synthesis, antimalarial activity, and preclinical pharmacology of a novel series of 4\u2032-fluoro and 4\u2032-chloro analogues of amodiaquine. Identification of a suitable \u201cback-up\u201d compound for N-tert-butyl isoquine","volume":"52","author":"O'Neill","year":"2009","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2019.05.043_bib18","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1021\/jm00035a017","article-title":"The effect of fluorine substitution on the metabolism and antimalarial activity of amodiaquine","volume":"37","author":"O'Neill","year":"1994","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2019.05.043_bib19","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1021\/jm8012618","article-title":"Candidate selection and preclinical evaluation of N-tert-butyl isoquine (GSK369796), an affordable and effective 4-aminoquinoline antimalarial for the 21st century","volume":"52","author":"O'Neill","year":"2009","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2019.05.043_bib20","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1038\/nrd4573","article-title":"Malaria medicines: a glass half full?","volume":"14","author":"Wells","year":"2015","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2019.05.043_bib21","doi-asserted-by":"crossref","first-page":"3091","DOI":"10.1016\/j.ejmech.2009.02.024","article-title":"Recent developments in the design and synthesis of hybrid molecules basedon aminoquinoline ring and their antiplasmodial evaluation","volume":"44","author":"Kouznetsov","year":"2009","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.05.043_bib22","first-page":"115","article-title":"Introducing new antimalarial analogues of chloroquine and amodiaquine: a narrative review","volume":"42","author":"Parhizgar","year":"2017","journal-title":"Iran. J. Med. Sci."},{"key":"10.1016\/j.ejmech.2019.05.043_bib23","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.2174\/1568026614666140808125728","article-title":"4-Aminoquinoline based molecular hybrids as antimalarials: an overview","volume":"14","author":"Manohar","year":"2014","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.05.043_bib24","doi-asserted-by":"crossref","first-page":"332","DOI":"10.2174\/1389557514666140220123226","article-title":"Quinoline\u2013a promising fragment in the search for new antimalarials","volume":"14","author":"Gryzlo","year":"2014","journal-title":"Mini Rev. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.05.043_bib25","doi-asserted-by":"crossref","first-page":"5120","DOI":"10.1016\/j.bmc.2015.04.017","article-title":"From hybrid compounds to targeted drug delivery in antimalarial therapy","volume":"23","author":"Oliveira","year":"2015","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.05.043_bib26","doi-asserted-by":"crossref","first-page":"5098","DOI":"10.1016\/j.bmc.2014.12.018","article-title":"Quinoline-based antimalarial hybrid compounds","volume":"23","author":"Vandekerckhove","year":"2015","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.05.043_bib27","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.ejmech.2016.08.039","article-title":"Hybrid molecules: the privileged scaffolds for various pharmaceuticals","volume":"124","author":"Mishra","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.05.043_bib28","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1021\/ml400311r","article-title":"J.\u00a0Gut. Synthesis and in\u00a0vitro and in\u00a0vivo pharmacological evaluation of new 4-aminoquinoline-based compounds","volume":"4","author":"Tukulula","year":"2013","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2019.05.043_bib29","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.ejmech.2013.05.023","article-title":"Synthesis and bioevaluation of novel 4-aminoquinoline-tetrazole derivatives as potent antimalarial agents","volume":"66","author":"Pandey","year":"2013","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.05.043_bib30","doi-asserted-by":"crossref","first-page":"4149","DOI":"10.1021\/ol801726k","article-title":"Codinaeopsin, an antimalarial fungal polyketide","volume":"10","author":"Kontnik","year":"2008","journal-title":"Org. Lett."},{"key":"10.1016\/j.ejmech.2019.05.043_bib31","doi-asserted-by":"crossref","first-page":"6412","DOI":"10.1021\/jo000307g","article-title":"Ascosalipyrrolidinone a, an antimicrobial alkaloid, from the obligate marine fungus Ascochyta s alicorniae","volume":"65","author":"Osterhage","year":"2000","journal-title":"J.\u00a0Org. Chem."},{"key":"10.1016\/j.ejmech.2019.05.043_bib32","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1021\/jm301076q","article-title":"Incorporation of a 3-(2, 2, 2-trifluoroethyl)-\u03b3-hydroxy-\u03b3-lactam motif in the side chain of 4-aminoquinolines. Syntheses and antimalarial activities","volume":"56","author":"Cornut","year":"2012","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2019.05.043_bib33","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1182\/blood.V72.1.358.358","article-title":"Antimalarial properties of orally active iron chelators","volume":"72","author":"Heppner","year":"1988","journal-title":"Blood"},{"key":"10.1016\/j.ejmech.2019.05.043_bib34","doi-asserted-by":"crossref","first-page":"3263","DOI":"10.1016\/j.bmcl.2014.06.012","article-title":"Kojic acid derived hydroxypyridinone\u2013chloroquine hybrids: synthesis, crystal structure, antiplasmodial activity and \u03b2-haematin inhibition","volume":"24","author":"Andayi","year":"2014","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2019.05.043_bib35","series-title":"Hetrocyclic Compounds","author":"Calderon","year":"2007"},{"key":"10.1016\/j.ejmech.2019.05.043_bib36","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1021\/jm0155704","article-title":"Rhodacyanine dyes as antimalarials. 1. Preliminary evaluation of their activity and toxicity","volume":"45","author":"Takasu","year":"2002","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2019.05.043_bib37","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1021\/jm061257w","article-title":"Discovery of a rhodanine class of compounds as inhibitors ofPlasmodium falciparum enoyl-acyl carrier protein reductase","volume":"50","author":"Kumar","year":"2007","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2019.05.043_bib38","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.ejmech.2013.01.017","article-title":"Synthesis and biological evaluation of a new class of 4-aminoquinoline\u2013rhodanine hybrid as potent anti-infective agents","volume":"62","author":"Chauhan","year":"2013","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.05.043_bib39","doi-asserted-by":"crossref","first-page":"2234","DOI":"10.1016\/j.bmcl.2010.02.017","article-title":"Comparison of the antiplasmodial and falcipain-2 inhibitory activity of \u03b2-amino alcohol thiolactone-chalcone and isatin-chalcone hybrids","volume":"20","author":"Hans","year":"2010","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2019.05.043_bib40","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.ejmech.2014.07.064","article-title":"\u03b2-amino-alcohol tethered 4-aminoquinoline-isatin conjugates: synthesis and antimalarial evaluation","volume":"84","author":"Nisha","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.05.043_bib41","doi-asserted-by":"crossref","first-page":"5455","DOI":"10.1016\/j.bmcl.2012.07.028","article-title":"Synthesis and in\u00a0vitro evaluation of new chloroquine-chalcone hybrids against chloroquine-resistant strain of Plasmodium falciparum","volume":"22","author":"Sashidhara","year":"2012","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2019.05.043_bib42","first-page":"1128","article-title":"Synthesis, in\u00a0vitro antimalarial activity and cytotoxicity of novel 4-aminoquinolinyl-chalcone amides Bioorg","volume":"22","author":"Smit","year":"2014","journal-title":"Med. Chem."},{"key":"10.1016\/j.ejmech.2019.05.043_bib43","doi-asserted-by":"crossref","first-page":"3573","DOI":"10.1016\/j.bmc.2014.05.024","article-title":"Antiplasmodial activity of new 4-aminoquinoline derivatives against chloroquine resistant strain","volume":"22","author":"Sinha","year":"2014","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.05.043_bib44","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.ejmech.2014.08.054","article-title":"Highly potent anti-proliferative effects of a gallium (III) complex with 7-chloroquinoline thiosemicarbazone as a ligand: synthesis, cytotoxic and antimalarial evaluation","volume":"86","author":"Kumar","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.05.043_bib45","doi-asserted-by":"crossref","first-page":"5419","DOI":"10.1016\/j.bmc.2015.07.051","article-title":"Antimalarial benzoheterocyclic 4-aminoquinolines: structure\u2013activity relationship, in\u00a0vivo evaluation, mechanistic and bioactivation studies","volume":"23","author":"Ongarora","year":"2015","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.05.043_bib46","doi-asserted-by":"crossref","first-page":"5046","DOI":"10.1016\/j.bmcl.2012.06.010","article-title":"Benzoheterocyclic amodiaquine analogues with potent antiplasmodial activity: synthesis and pharmacological evaluation","volume":"22","author":"Ongarora","year":"2012","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2019.05.043_bib47","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1021\/jm901178d","article-title":"Synthesis and antiprotozoal activity of cationic 1, 4-diphenyl-1 H-1, 2, 3-triazoles","volume":"53","author":"Bakunov","year":"2009","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2019.05.043_bib48","doi-asserted-by":"crossref","first-page":"4561","DOI":"10.1016\/j.bmcl.2011.05.119","article-title":"Antiplasmodial and cytotoxicity evaluation of 3-functionalized 2-azetidinone derivatives","volume":"21","author":"Singh","year":"2011","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2019.05.043_bib49","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/cbdd.12321","article-title":"New compounds hybrids 1H-1, 2, 3-triazole-quinoline AgainstPlasmodium falciparum","volume":"84","author":"Boechat","year":"2014","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.ejmech.2019.05.043_bib50","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1111\/cbdd.12335","article-title":"Synthesis and evaluation of antimalarial properties of novel 4-aminoquinoline hybrid compounds","volume":"84","author":"Fisher","year":"2014","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.ejmech.2019.05.043_bib51","doi-asserted-by":"crossref","first-page":"4163","DOI":"10.1016\/j.bmc.2015.06.044","article-title":"In\u00a0vitro antiplasmodial activity of triazole-linked chloroquinoline derivatives synthesized from 7-chloro-N-(prop-2-yn-1-yl) quinolin-4-amine","volume":"23","author":"Taleli","year":"2015","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.05.043_bib52","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.1016\/j.bmc.2015.02.061","article-title":"Investigation into novel thiophene-and furan-based 4-amino-7-chloroquinolines afforded antimalarials that cure mice","volume":"23","author":"Opsenica","year":"2015","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.05.043_bib53","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1016\/j.bmcl.2016.03.027","article-title":"New pentasubstituted pyrrole hybrid atorvastatin\u2013quinoline derivatives with antiplasmodial activity","volume":"26","author":"Carvalho","year":"2016","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2019.05.043_bib54","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1128\/AAC.01462-08","article-title":"Atorvastatin is a promising partner for antimalarial drugs in treatment of Plasmodium falciparum malaria","volume":"53","author":"Parquet","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2019.05.043_bib55","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1186\/1475-2875-9-139","article-title":"Atorvastatin as a potential anti-malarial drug: in\u00a0vitro synergy in combinational therapy with quinine against Plasmodium falciparum","volume":"9","author":"Parquet","year":"2010","journal-title":"Malar. J."},{"key":"10.1016\/j.ejmech.2019.05.043_bib56","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.1016\/j.bmcl.2015.04.014","article-title":"New quinoline derivatives demonstrate a promising antimalarial activity againstPlasmodium falciparum in\u00a0vitro and Plasmodium berghei in\u00a0vivo","volume":"25","author":"Soares","year":"2015","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2019.05.043_bib57","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/cbdd.12289","article-title":"Chauhan design and synthesis of a new class of 4-Aminoquinolinyl-and 9-anilinoacridinyl schiff base hydrazones as potent antimalarial agents","volume":"84","author":"Sharma","year":"2014","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.ejmech.2019.05.043_bib58","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.ejmech.2014.11.065","article-title":"Synthesis and in\u00a0vitro antiplasmodial activity of ferrocenyl aminoquinoline derivatives","volume":"90","author":"Maguene","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.05.043_bib59","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.ejmech.2015.03.045","article-title":"Synthesis and in\u00a0vitro antiplasmodial evaluation of 7-chloroquinoline\u2013chalcone and 7-chloroquinoline\u2013ferrocenylchalcone conjugates","volume":"95","author":"Raj","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.05.043_bib60","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.ejmech.2015.06.024","article-title":"Synthesis, antiplasmodial activity and mechanistic studies of pyrimidine- 5-carbonitrile and quinoline hybrids","volume":"101","author":"Kaur","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.05.043_bib61","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1021\/jm00156a009","article-title":"Antimalarial drugs. 60. Synthesis, antimalarial activity, and quantitative structure-activity relationships of tebuquine and a series of related 5-[(7-chloro-4-quinolinyl) amino]-3-[(alkylamino) methyl][1, 1'-biphenyl]-2-ols and N. omega.-oxides","volume":"29","author":"Werbel","year":"1986","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2019.05.043_bib62","doi-asserted-by":"crossref","first-page":"4755","DOI":"10.1016\/j.bmc.2015.05.040","article-title":"Synthesis, \u03b2-hematin inhibition studies and antimalarial evaluation of dehydroxy isotebuquine derivatives against Plasmodium berghei","volume":"23","author":"Romero","year":"2015","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.05.043_bib63","doi-asserted-by":"crossref","first-page":"4657","DOI":"10.1016\/j.bmcl.2015.08.030","article-title":"Synthesis, in\u00a0vitro and in silico antimalarial activity of 7-chloroquinoline and 4H-chromene conjugates","volume":"25","author":"Parthiban","year":"2015","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2019.05.043_bib64","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.ejmech.2013.06.049","article-title":"Synthesis of novel analogs of 2-pyrazoline obtained from [(7-chloroquinolin-4-yl) amino] chalcones and hydrazine as potential antitumor and antimalarial agents","volume":"67","author":"Insuasty","year":"2013","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.05.043_bib65","doi-asserted-by":"crossref","first-page":"6956","DOI":"10.1021\/jm2009698","article-title":"Quinoline antimalarials containing a dibemethin group are active against chloroquinone-resistant Plasmodium falciparum and inhibit chloroquine transport via the P. falciparum chloroquine-resistance transporter (PfCRT)","volume":"54","author":"Zishiri","year":"2011","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2019.05.043_bib66","doi-asserted-by":"crossref","first-page":"8243","DOI":"10.1016\/j.bmc.2010.10.009","article-title":"Design, synthesis and in\u00a0vitro antimalarial evaluation of triazole-linked chalcone and dienone hybrid compounds","volume":"18","author":"Guantai","year":"2010","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.05.043_bib67","doi-asserted-by":"crossref","first-page":"3637","DOI":"10.1021\/jm200149e","article-title":"Enone\u2013and chalcone\u2013chloroquinoline hybrid analogues: in silico guided design, synthesis, antiplasmodial activity, in\u00a0vitro metabolism, and mechanistic studies","volume":"54","author":"Guantai","year":"2011","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2019.05.043_bib68","doi-asserted-by":"crossref","first-page":"10387","DOI":"10.1021\/jm300831b","article-title":"Mimicking the intramolecular hydrogen bond: synthesis, biological evaluation, and molecular modeling of benzoxazines and quinazolines as potential antimalarial agents","volume":"55","author":"Gemma","year":"2012","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2019.05.043_bib69","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1021\/jm4014778","article-title":"Quinoline\u2013pyrimidine hybrids: synthesis, antiplasmodial activity, SAR, and mode of action studies","volume":"57","author":"Singh","year":"2013","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2019.05.043_bib70","doi-asserted-by":"crossref","first-page":"4134","DOI":"10.1021\/jm500033r","article-title":"Second generation steroidal 4-aminoquinolines are potent, dual-target inhibitors of the botulinum neurotoxin serotype A metalloprotease and P. falciparum malaria","volume":"57","author":"Videnovi\u0107","year":"2014","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2019.05.043_bib71","doi-asserted-by":"crossref","first-page":"489","DOI":"10.4103\/IJMR.2010_132_05_489","article-title":"Botulinum toxin: bioweapon & magic drug","volume":"132","author":"Dhaked","year":"2010","journal-title":"Indian J. Med. Res."},{"key":"10.1016\/j.ejmech.2019.05.043_bib72","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1001\/jama.285.8.1059","article-title":"Botulinum toxin as a biological weapon: medical and public health management","volume":"285","author":"Arnon","year":"2001","journal-title":"Jama"},{"key":"10.1016\/j.ejmech.2019.05.043_bib73","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1016\/j.bmcl.2011.01.103","article-title":"Synthesis, in\u00a0vitro antimalarial and cytotoxicity of artemisinin-aminoquinoline hybrids","volume":"vol. 21","author":"Lombard","year":"2011","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2019.05.043_bib74","series-title":"Formulation of dihydroartemisinin for the control of wide spectrum of malaria","author":"Jain","year":"2001"},{"key":"10.1016\/j.ejmech.2019.05.043_bib75","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1039\/c2md20011b","article-title":"Squaric acid: a valuable scaffold for developing antimalarials?","volume":"3","author":"Kumar","year":"2012","journal-title":"MedChemComm"},{"key":"10.1016\/j.ejmech.2019.05.043_bib76","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.ejmech.2013.08.037","article-title":"Squaric acid\/4-aminoquinoline conjugates: novel potent antiplasmodial agents","volume":"69","author":"Ribeiro","year":"2013","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.05.043_bib77","doi-asserted-by":"crossref","first-page":"5156","DOI":"10.1016\/j.bmc.2015.01.031","article-title":"Synthesis, biological profiling and mechanistic studies of 4-aminoquinoline-based heterodimeric compounds with dual trypanocidal\u2013antiplasmodial activity","volume":"23","author":"Sola","year":"2015","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.05.043_bib78","doi-asserted-by":"crossref","first-page":"5435","DOI":"10.1016\/j.bmcl.2014.10.025","article-title":"Synthesis and antiprotozoal activity of oligomethylene-and p-phenylene-bis (methylene)-linked bis (+)-huprines","volume":"24","author":"Sola","year":"2014","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2019.05.043_bib79","doi-asserted-by":"crossref","first-page":"6200","DOI":"10.1021\/jm400656s","article-title":"Novel conjugated quinoline\u2013indoles compromisePlasmodium falciparum mitochondrial function and show promising antimalarial activity","volume":"56","author":"Teguh","year":"2013","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2019.05.043_bib80","doi-asserted-by":"crossref","first-page":"7084","DOI":"10.1021\/jm200636z","article-title":"Synthesis and evaluation of 7-substituted 4-aminoquinoline analogues for antimalarial activity","volume":"54","author":"Hwang","year":"2011","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2019.05.043_bib81","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002178","article-title":"The next opportunity in anti-malaria drug discovery: the liver stage","volume":"7","author":"Derbyshire","year":"2011","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.ejmech.2019.05.043_bib82","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/j.ejmech.2008.08.011","article-title":"Primaquine revisited six decades after its discovery","volume":"44","author":"Vale","year":"2009","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.05.043_bib83","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1086\/424663","article-title":"Primaquine therapy for malaria","volume":"39","author":"Baird","year":"2004","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ejmech.2019.05.043_bib84","series-title":"Testing for G6PD Deficiency for Safe Use of Primaquine in Radical Cure of P. Vivax and P. Ovale: Policy Brief","author":"World Health Organization","year":"2016"},{"key":"10.1016\/j.ejmech.2019.05.043_bib85","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/B978-0-12-407826-0.00004-7","article-title":"G6PD deficiency: global distribution, genetic variants and primaquine therapy","volume":"81","author":"Howes","year":"2013","journal-title":"Adv. Parasitol."},{"key":"10.1016\/j.ejmech.2019.05.043_bib86","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1021\/jm00351a017","article-title":"Antimalarials. 14. 5-(Aryloxy)-4-methylprimaquine analogs. A highly effective series of blood and tissue schizonticidal agents","volume":"25","author":"LaMontagne","year":"1982","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2019.05.043_bib87","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1021\/jm00128a010","article-title":"Antimalarials. 16. Synthesis of 2-substituted analogs of 8-[(4-amino-1-methylbutyl) amino]-6-methoxy-4-methyl- 5-[3-(trifluoromethyl) phenoxy] quinoline as candidate antimalarials","volume":"32","author":"LaMontagne","year":"1989","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2019.05.043_bib88","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1124\/jpet.103.062984","article-title":"Primaquine-induced hemolytic anemia: susceptibility of normal versus glutathione-depleted rat erythrocytes to 5-hydroxyprimaquine","volume":"309","author":"Bowman","year":"2004","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejmech.2019.05.043_bib89","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1021\/jm201095h","article-title":"Targeting the liver stage of malaria parasites: a yet unmet goal","volume":"55","author":"Rodrigues","year":"2011","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2019.05.043_bib91","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/S0140-6736(13)62568-4","article-title":"Tafenoquine plus chloroquine for the treatment and relapse prevention of Plasmodium vivax malaria (DETECTIVE): a multicentre, double-blind, randomised, phase 2b dose-selection study","volume":"383","author":"Llanos-Cuentas","year":"2014","journal-title":"The Lancet"},{"key":"10.1016\/j.ejmech.2019.05.043_bib92","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.bmc.2010.11.036","article-title":"Synthesis, antiprotozoal, antimicrobial, \u03b2-hematin inhibition, cytotoxicity and methemoglobin (MetHb) formation activities of bis (8-aminoquinolines)","volume":"19","author":"Kaur","year":"2011","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.05.043_bib93","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.ejmech.2015.06.045","article-title":"Primaquine\u2013pyrimidine hybrids: synthesis and dual-stage antiplasmodial activity","volume":"101","author":"Kaur","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.05.043_bib94","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/j.bmcl.2015.01.003","article-title":"Synthesis and in\u00a0vitro evaluation of novel 8-aminoquinoline\u2013pyrazolopyrimidine hybrids as potent antimalarial agents","volume":"25","author":"Kannan","year":"2015","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2019.05.043_bib95","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.ejmech.2012.03.019","article-title":"Amino acid, dipeptide and pseudodipeptide conjugates of ring-substituted 8-aminoquinolines: synthesis and evaluation of anti-infective, \u03b2-haematin inhibition and cytotoxic activities","volume":"52","author":"Kaur","year":"2012","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.05.043_bib96","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1128\/AAC.05345-11","article-title":"Novel potent metallocenes against liver stage malaria","volume":"56","author":"Matos","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2019.05.043_bib97","doi-asserted-by":"crossref","first-page":"4698","DOI":"10.1128\/AAC.05133-11","article-title":"Design and evaluation of primaquine-artemisinin hybrids as a multistage antimalarial strategy","volume":"55","author":"Capela","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2019.05.043_bib98","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1111\/cbdd.12944","article-title":"Synthesis of primaquine glyco-conjugates as potential tissue schizontocidal antimalarial agents","volume":"90","author":"Azad","year":"2017","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.ejmech.2019.05.043_bib99","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/j.2042-7158.1998.tb06173.x","article-title":"The pharmacokinetics and bioavailability of dihydroartemisinin, arteether, artemether, artesunic acid and artelinic acid in rats","volume":"50","author":"Li","year":"1998","journal-title":"J.\u00a0Pharm. Pharmacol."},{"key":"10.1016\/j.ejmech.2019.05.043_bib100","doi-asserted-by":"crossref","first-page":"255","DOI":"10.2165\/00003088-200039040-00002","article-title":"Pharmacokinetics of artemisinin-type compounds","volume":"39","author":"Navaratnam","year":"2000","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.ejmech.2019.05.043_bib101","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1039\/B816679J","article-title":"Artemisinin and its derivatives: a novel class of anti-malarial and anti-cancer agents","volume":"39","author":"Chaturvedi","year":"2010","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.ejmech.2019.05.043_bib102","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1586\/eri.09.68","article-title":"Discovery, mechanisms of action and combination therapy of artemisinin","volume":"7","author":"Cui","year":"2009","journal-title":"Expert Rev. Anti Infect.Ther."},{"key":"10.1016\/j.ejmech.2019.05.043_bib103","doi-asserted-by":"crossref","first-page":"11221","DOI":"10.1021\/cr500543f","article-title":"Antimalarials in development in 2014","volume":"114","author":"Barnett","year":"2014","journal-title":"Chem. Rev."},{"key":"10.1016\/j.ejmech.2019.05.043_bib104","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1021\/jm901216v","article-title":"Modular synthesis and in\u00a0vitro and in\u00a0vivo antimalarial assessment of C-10 pyrrole mannich base derivatives of artemisinin","volume":"53","author":"Pacorel","year":"2009","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2019.05.043_bib105","doi-asserted-by":"crossref","first-page":"7992","DOI":"10.1021\/jm3009986","article-title":"Malaria-infected mice live until at least day 30 after a new artemisinin-derived thioacetal thiocarbonate combined with mefloquine are administered together in a single, low, oral dose","volume":"55","author":"Jacobine","year":"2012","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2019.05.043_bib106","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1016\/j.bmcl.2016.02.019","article-title":"New orally active diphenylmethyl-based ester analogues of dihydroartemisinin: synthesis and antimalarial assessment against multidrug-resistant Plasmodium yoelii nigeriensis in mice","volume":"26","author":"Chaudhary","year":"2016","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2019.05.043_bib107","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.ejmech.2014.11.016","article-title":"Synthesis and in\u00a0vitro biological evaluation of dihydroartemisinyl-chalcone esters","volume":"90","author":"Smit","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.05.043_bib108","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.bmcl.2014.11.064","article-title":"Antimalarial chemotherapy: orally curative artemisinin-derived trioxane dimer esters","volume":"25","author":"Conyers","year":"2015","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2019.05.043_bib109","doi-asserted-by":"crossref","first-page":"5452","DOI":"10.1016\/j.bmc.2015.07.048","article-title":"Highly potent artemisinin-derived dimers and trimers: synthesis and evaluation of their antimalarial, antileukemia and antiviral activities","volume":"23","author":"Reiter","year":"2015","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.05.043_bib110","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1021\/jm020461q","article-title":"Orally active, antimalarial, anticancer, artemisinin-derived trioxane dimers with high stability and efficacy","volume":"46","author":"Posner","year":"2003","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2019.05.043_bib111","doi-asserted-by":"crossref","first-page":"2440","DOI":"10.1016\/j.bmcl.2014.04.025","article-title":"Antimalarial chemotherapy: artemisinin-derived dimer carbonates and thiocarbonates","volume":"24","author":"Mazzone","year":"2014","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2019.05.043_bib112","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.ejmech.2015.04.053","article-title":"New efficient artemisinin derived agents against human leukemia cells, human cytomegalovirus and Plasmodium falciparum: 2nd generation 1, 2, 4-trioxane-ferrocene hybrids","volume":"97","author":"Reiter","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.05.043_bib113","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1021\/jm201214d","article-title":"Malaria-infected mice are completely cured by one 6 mg\/kg oral dose of a new monomeric trioxane sulfide combined with mefloquine","volume":"55","author":"Slack","year":"2011","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2019.05.043_bib114","doi-asserted-by":"crossref","first-page":"2630","DOI":"10.1021\/jm400058j","article-title":"Synthesis and antimalarial efficacy of two-carbon-linked, artemisinin-derived trioxane dimers in combination with known antimalarial drugs","volume":"56","author":"Mott","year":"2013","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2019.05.043_bib115","doi-asserted-by":"crossref","first-page":"5693","DOI":"10.1002\/anie.201001026","article-title":"Identification of a 1, 2, 4, 5-tetraoxane antimalarial drug-development candidate (RKA 182) with superior properties to the semisynthetic artemisinins","volume":"49","author":"O'Neill","year":"2010","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.ejmech.2019.05.043_bib116","doi-asserted-by":"crossref","first-page":"6443","DOI":"10.1021\/jm200768h","article-title":"Comparison of the reactivity of antimalarial 1, 2, 4, 5-tetraoxanes with 1, 2, 4-trioxolanes in the presence of ferrous iron salts, heme, and ferrous iron salts\/phosphatidylcholine","volume":"54","author":"Bousejra-El Garah","year":"2011","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2019.05.043_bib117","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1021\/acs.jmedchem.5b01374","article-title":"Are 4-aminoquinolines and tetraoxanes potential two-stage antimalarials?","volume":"59","author":"Terzic","year":"2015","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2019.05.043_bib118","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1021\/ml4002985","article-title":"Novel endoperoxide-based transmission-blocking antimalarials with liver-and blood-schizontocidal activities","volume":"5","author":"Miranda","year":"2013","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2019.05.043_bib119","doi-asserted-by":"crossref","first-page":"4916","DOI":"10.1021\/jm5004528","article-title":"Tetraoxane\u2013pyrimidine nitrile hybrids as dual stage antimalarials","volume":"57","author":"Oliveira","year":"2014","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2019.05.043_bib120","series-title":"Combination of atovaquone and proguanil for the treatment of protozoal infections","author":"Gutteridge","year":"2000"},{"key":"10.1016\/j.ejmech.2019.05.043_bib121","doi-asserted-by":"crossref","first-page":"2775","DOI":"10.1002\/hlca.19930760804","article-title":"Synthesis, structure, and antimalarial activity of tricyclic 1, 2, 4-trioxanes related to artemisinin","volume":"76","author":"Jefford","year":"1993","journal-title":"Helv. Chim. Acta"},{"key":"10.1016\/j.ejmech.2019.05.043_bib122","doi-asserted-by":"crossref","first-page":"4400","DOI":"10.1073\/pnas.1015762108","article-title":"Synthetic ozonide drug candidate OZ439 offers new hope for a single-dose cure of uncomplicated malaria","volume":"108","author":"Charman","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.ejmech.2019.05.043_bib123","doi-asserted-by":"crossref","first-page":"2945","DOI":"10.1002\/jps.20958","article-title":"Iron-mediated degradation kinetics of substituted dispiro-1, 2, 4-trioxolane antimalarials","volume":"96","author":"Creek","year":"2007","journal-title":"J.\u00a0Pharm. Sci."},{"key":"10.1016\/j.ejmech.2019.05.043_bib124","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1021\/jm400004u","article-title":"Comparative antimalarial activities and ADME profiles of ozonides (1, 2, 4-trioxolanes) OZ277, OZ439, and their 1, 2-dioxolane, 1, 2, 4-trioxane, and 1, 2, 4, 5-tetraoxane isosteres","volume":"56","author":"Wang","year":"2013","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2019.05.043_bib125","first-page":"1","article-title":"Single ascending dose safety and pharmacokinetics of CDRI-97\/79: first-in-human study of a novel antimalarial drug","author":"Shafiq","year":"2014","journal-title":"Malar. Res. Treat."},{"key":"10.1016\/j.ejmech.2019.05.043_bib126","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1055\/s-0032-1306317","article-title":"Intersex effect of lamotrigine on the pharmacokinetic parameters of CDRI-97\/79, a novel trioxane antimalarial compound, in rats","volume":"62","author":"Kushwaha","year":"2012","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.ejmech.2019.05.043_bib127","doi-asserted-by":"crossref","first-page":"10662","DOI":"10.1021\/jm301323k","article-title":"Bile acid-based 1, 2, 4-trioxanes: synthesis and antimalarial assessment (1)","volume":"55","author":"Singh","year":"2012","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2019.05.043_bib128","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s00044-016-1769-6","article-title":"Synthesis of an organo-ruthenium aminoquinoline-trioxane hybrid and evaluation of its activity against Plasmodium falciparum and its toxicity toward normal mammalian cells","volume":"26","author":"Mart\u00ednez","year":"2017","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.ejmech.2019.05.043_bib129","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.ejmech.2015.11.020","article-title":"Synthesis and antimalarial activity of quinones and structurally-related oxirane derivatives","volume":"108","author":"Carneiro","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.05.043_bib130","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1021\/jm201184h","article-title":"Identification, design and biological evaluation of heterocyclic quinolones targeting Plasmodium falciparum type II NADH: quinone oxidoreductase (PfNDH2)","volume":"55","author":"Leung","year":"2012","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2019.05.043_bib131","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1021\/jm201179h","article-title":"Identification, design and biological evaluation of bisaryl quinolones targeting Plasmodium falciparum type II NADH: quinone oxidoreductase (PfNDH2)","volume":"55","author":"Pidathala","year":"2012","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2019.05.043_bib132","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.ejmech.2012.02.006","article-title":"Synthesis and in\u00a0vitro antiplasmodial activities of fluoroquinolone analogs","volume":"51","author":"Dixit","year":"2012","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.05.043_bib133","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.exppara.2010.10.016","article-title":"Optimization of endochin-like quinolones for antimalarial activity","volume":"127","author":"Winter","year":"2011","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.ejmech.2019.05.043_bib134","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.4155\/fmc.12.177","article-title":"Exploration of 4 (1H)-pyridones as a novel family of potent antimalarial inhibitors of the plasmodial cytochrome bc1","volume":"4","author":"Bueno","year":"2012","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.ejmech.2019.05.043_bib135","doi-asserted-by":"crossref","first-page":"5214","DOI":"10.1016\/j.bmcl.2011.07.044","article-title":"Potent antimalarial 4-pyridones with improved physico-chemical properties","volume":"21","author":"Bueno","year":"2011","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2019.05.043_bib136","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.molbiopara.2008.01.002","article-title":"A\u00a0drug-selected Plasmodium falciparum lacking the need for conventional electron transport","volume":"159","author":"Smilkstein","year":"2008","journal-title":"Mol. Biochem. Parasitol."},{"key":"10.1016\/j.ejmech.2019.05.043_bib137","doi-asserted-by":"crossref","first-page":"4533","DOI":"10.1128\/AAC.00519-09","article-title":"Improved murine model of malaria using Plasmodium falciparum competent strains and non-myelodepleted NOD-scid IL2R\u03b3null mice engrafted with human erythrocytes","volume":"53","author":"Jim\u00e9nez-D\u00edaz","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2019.05.043_bib138","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1126\/scitranslmed.3005029","article-title":"Quinolone-3-diarylethers: a new class of antimalarial drug","volume":"5","author":"Nilsen","year":"2013","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ejmech.2019.05.043_bib139","doi-asserted-by":"crossref","first-page":"8860","DOI":"10.1021\/jm500942v","article-title":"Orally bioavailable 6-Chloro-7-methoxy-4 (1 H)-quinolones efficacious against multiple stages of plasmodium","volume":"57","author":"Cross","year":"2014","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2019.05.043_bib140","doi-asserted-by":"crossref","first-page":"4583","DOI":"10.1016\/j.bmcl.2013.06.033","article-title":"In\u00a0vivo antimalarial activity of novel 2-hydroxy-3-anilino-1, 4-naphthoquinones obtained by epoxide ring-opening reaction","volume":"23","author":"de Rezende","year":"2013","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2019.05.043_bib141","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.ejmech.2012.10.052","article-title":"Addition of thiols to o-quinone methide: new 2-hydroxy-3-phenylsulfanylmethyl [1, 4] naphthoquinones and their activity against the human malaria parasitePlasmodium falciparum (3D7)","volume":"59","author":"Sharma","year":"2013","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.05.043_bib142","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.ejmech.2015.09.001","article-title":"Novel 1, 4-naphthoquinone-based sulfonamides: synthesis, QSAR, anticancer and antimalarial studies","volume":"103","author":"Pingaew","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.05.043_bib143","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.ejmech.2013.10.011","article-title":"Synthesis and biological evaluation of novel ferrocene\u2013naphthoquinones as antiplasmodial agents","volume":"70","author":"Garc\u00eda-Barrantes","year":"2013","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.05.043_bib144","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1021\/jm901545z","article-title":"Transforming rhinacanthin analogues from potent anticancer agents into potent antimalarial agents","volume":"53","author":"Kongkathip","year":"2010","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2019.05.043_bib145","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1021\/jm901300d","article-title":"Synthesis and antiplasmodial activity of new indolone N-oxide derivatives","volume":"53","author":"Nepveu","year":"2009","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2019.05.043_bib146","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.2174\/1568026614666140808121329","article-title":"Antimalarial activities of indolones and derivatives","volume":"14","author":"Nepveu","year":"2014","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.05.043_bib147","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.ejmech.2014.03.059","article-title":"2-Aryl-3H-indol-3-ones: synthesis, electrochemical behaviour and antiplasmodial activities","volume":"79","author":"Najahi","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.05.043_bib148","doi-asserted-by":"crossref","first-page":"5634","DOI":"10.1016\/j.bmcl.2010.08.043","article-title":"Bis-alkylamine quindolone derivatives as new antimalarial leads","volume":"20","author":"Lavrado","year":"2010","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2019.05.043_bib149","series-title":"Indolo[2,1-b] quinazole-6,12-dione antimalarial compounds and method of treating malaria therewith","author":"Pitzer","year":"2003"},{"key":"10.1016\/j.ejmech.2019.05.043_bib150","doi-asserted-by":"crossref","first-page":"5757","DOI":"10.1016\/j.bmc.2014.09.040","article-title":"Synthesis and evaluation of the antiplasmodial activity of novel indeno [2, 1-c] quinoline derivatives","volume":"22","author":"Barteselli","year":"2014","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.05.043_bib151","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.ejmech.2013.03.072","article-title":"Synthesis and antimalarial testing of neocryptolepine analogues: addition of ester function in SAR study of 2, 11-disubstituted indolo [2, 3-b] quinolines","volume":"64","author":"Lu","year":"2013","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.05.043_bib152","doi-asserted-by":"crossref","first-page":"2629","DOI":"10.1016\/j.bmc.2014.03.030","article-title":"Synthesis, \u03b2-haematin inhibition, and in\u00a0vitro antimalarial testing of isocryptolepine analogues: SAR study of indolo [3, 2-c] quinolines with various substituents at C2, C6, and N11","volume":"22","author":"Wang","year":"2014","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.05.043_bib153","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ejmech.2015.02.047","article-title":"Synthesis of isocryptolepine analogues and their structure\u2013activity relationship studies as antiplasmodial and antiproliferative agents","volume":"94","author":"Aroonkit","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.05.043_bib154","doi-asserted-by":"crossref","first-page":"13704","DOI":"10.3390\/ijms140713704","article-title":"Melatonin signaling and its modulation of PfNF-YB transcription factor expression in Plasmodium falciparum","volume":"14","author":"Lima","year":"2013","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2019.05.043_bib155","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.ejmech.2014.03.055","article-title":"Synthetic indole and melatonin derivatives exhibit antimalarial activity on the cell cycle of the human malaria parasite Plasmodium falciparum","volume":"79","author":"Schuck","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.05.043_bib156","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.ejmech.2015.07.047","article-title":"Exploring the 3-piperidin-4-yl-1H-indole scaffold as a novel antimalarial chemotype","volume":"102","author":"Santos","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.05.043_bib157","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.ejmech.2016.02.056","article-title":"Indolyl-3-ethanone-\u03b1-thioethers: a promising new class of non-toxic antimalarial agents","volume":"114","author":"Svogie","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.05.043_bib158","doi-asserted-by":"crossref","first-page":"3295","DOI":"10.1021\/jm500075d","article-title":"Bis-alkylamine indolo [3, 2-b] quinolines as hemozoin ligands: implications for antimalarial cytostatic and cytocidal activities","volume":"57","author":"Paulo","year":"2014","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2019.05.043_bib159","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1016\/j.bmc.2015.02.007","article-title":"N10, N11-di-alkylamine indolo [3, 2-b] quinolines as hemozoin inhibitors: design, synthesis and antiplasmodial activity","volume":"23","author":"Figueiras","year":"2015","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.05.043_bib160","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.ejmech.2015.05.020","article-title":"Synthesis, antimalarial and antitubercular activities of meridianin derivatives","volume":"98","author":"Yadav","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.05.043_bib161","doi-asserted-by":"crossref","first-page":"9059","DOI":"10.1073\/pnas.0802982105","article-title":"In silico activity profiling reveals the mechanism of action of antimalarials discovered in a high-throughput screen","volume":"105","author":"Plouffe","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.ejmech.2019.05.043_bib162","doi-asserted-by":"crossref","first-page":"5155","DOI":"10.1021\/jm100410f","article-title":"Spirotetrahydro \u03b2-carbolines (spiroindolones): a new class of potent and orally efficacious compounds for the treatment of malaria","volume":"53","author":"Yeung","year":"2010","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2019.05.043_bib163","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1126\/science.1193225","article-title":"Spiroindolones, a potent compound class for the treatment of malaria","volume":"329","author":"Rottmann","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2019.05.043_bib164","doi-asserted-by":"crossref","first-page":"3544","DOI":"10.1128\/AAC.06377-11","article-title":"The spiroindolone drug candidate NITD609 potently inhibits gametocytogenesis and blocks Plasmodium falciparum transmission to anopheles mosquito vector","volume":"56","author":"van Pelt-Koops","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2019.05.043_bib165","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJMoa1315860","article-title":"Spiroindolone KAE609 for falciparum and vivax malaria","volume":"371","author":"White","year":"2014","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ejmech.2019.05.043_bib166","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.4155\/fmc.12.178","article-title":"Hits, leads and drugs against malaria through diversity-oriented synthesis","volume":"4","author":"Dandapani","year":"2012","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.ejmech.2019.05.043_bib167","doi-asserted-by":"crossref","first-page":"5116","DOI":"10.1021\/jm2003359","article-title":"Imidazolopiperazines: Hit to lead optimization of new antimalarial agents","volume":"54","author":"Wu","year":"2011","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2019.05.043_bib168","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1126\/science.1211936","article-title":"Imaging of Plasmodium liver stages to drive next-generation antimalarial drug discovery","volume":"334","author":"Meister","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2019.05.043_bib169","doi-asserted-by":"crossref","first-page":"4244","DOI":"10.1021\/jm300041e","article-title":"Imidazolopiperazines: lead optimization of the second-generation antimalarial agents","volume":"55","author":"Nagle","year":"2012","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2019.05.043_bib170","doi-asserted-by":"crossref","first-page":"3479","DOI":"10.1021\/jm3001373","article-title":"3,5-Diaryl-2-aminopyridines as a novel class of orally active antimalarials demonstrating single dose cure in mice and clinical candidate potential","volume":"55","author":"Younis","year":"2012","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2019.05.043_bib171","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/1475-2875-13-S1-P38","article-title":"Identification of Plasmodium PI4 kinase as target of MMV390048 by chemoproteomics","volume":"13","author":"Ghidelli-Disse","year":"2014","journal-title":"Malar. J."},{"key":"10.1016\/j.ejmech.2019.05.043_bib172","doi-asserted-by":"crossref","first-page":"8860","DOI":"10.1021\/jm401278d","article-title":"Structure\u2013activity-relationship studies around the 2-amino group and pyridine core of antimalarial 3, 5-diarylaminopyridines lead to a novel series of pyrazine analogues with oral in\u00a0vivo activity","volume":"56","author":"Younis","year":"2013","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2019.05.043_bib173","doi-asserted-by":"crossref","first-page":"5540","DOI":"10.1021\/jm200592f","article-title":"Structure-guided lead optimization of triazolopyrimidine-ring substituents identifies potentPlasmodium falciparum dihydroorotate dehydrogenase inhibitors with clinical candidate potential","volume":"54","author":"Coteron","year":"2011","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2019.05.043_bib174","doi-asserted-by":"crossref","first-page":"5381","DOI":"10.1021\/jm500481t","article-title":"Fluorine modulates species selectivity in the triazolopyrimidine class of Plasmodium falciparum dihydroorotate dehydrogenase inhibitors","volume":"57","author":"Deng","year":"2014","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2019.05.043_bib175","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1021\/jm401760c","article-title":"2, 4-Diaminothienopyrimidines as orally active antimalarial agents","volume":"57","author":"Gonz\u00e1lez Cabrera","year":"2014","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2019.05.043_bib176","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.ejmech.2015.03.011","article-title":"Discovery of new thienopyrimidinone derivatives displaying antimalarial properties toward both erythrocytic and hepatic stages of Plasmodium","volume":"95","author":"Cohen","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.05.043_bib177","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejmech.2015.05.043","article-title":"Ferrocene-pyrimidine conjugates: synthesis, electrochemistry, physicochemical properties and antiplasmodial activities","volume":"100","author":"Chopra","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.05.043_bib178","author":"Saxena"},{"key":"10.1016\/j.ejmech.2019.05.043_bib179","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/S0140-6736(95)92712-3","article-title":"Effects of azithromycin on malariometric indices in the Gambia","volume":"346","author":"Sadiq","year":"1995","journal-title":"The Lancet"},{"key":"10.1016\/j.ejmech.2019.05.043_bib180","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1086\/508175","article-title":"Azithromycin combination therapy with artesunate or quinine for the treatment of uncomplicated Plasmodium falciparum malaria in adults: a randomized, phase 2 clinical trial in Thailand","volume":"43","author":"Noedl","year":"2006","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ejmech.2019.05.043_bib181","doi-asserted-by":"crossref","first-page":"3216","DOI":"10.1021\/jm201676t","article-title":"Design, synthesis, and in\u00a0vitro activity of novel 2\u2032-O-substituted 1 5-membered azalides","volume":"55","author":"Pe\u0161i\u0107","year":"2012","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2019.05.043_bib182","doi-asserted-by":"crossref","first-page":"3595","DOI":"10.1021\/jm2001585","article-title":"Synthesis, structure\u2013activity relationship, and antimalarial activity of ureas and thioureas of 1 5-membered azalides","volume":"54","author":"Bukvi\u0107 Kraja\u010di\u0107","year":"2011","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2019.05.043_bib183","doi-asserted-by":"crossref","first-page":"8496","DOI":"10.1021\/jm500994n","article-title":"Diversity-oriented synthesis-facilitated medicinal chemistry: toward the development of novel antimalarial agents","volume":"57","author":"Comer","year":"2014","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2019.05.043_bib184","doi-asserted-by":"crossref","first-page":"5502","DOI":"10.1016\/j.bmc.2015.07.038","article-title":"Antimalarial activity of prodrugs of N-branched acyclic nucleoside phosphonate inhibitors of 6-oxopurine phosphoribosyltransferases","volume":"23","author":"Hockov\u00e1","year":"2015","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.05.043_bib185","series-title":"Nucleoside Analogs and Uses in Treating Plasmodium Falciparum Infection","author":"Weis","year":"2001"},{"key":"10.1016\/j.ejmech.2019.05.043_bib186","first-page":"85","article-title":"Spirocyclic chromanes exhibit antiplasmodial activities and inhibit all intraerythrocytic life cycle stages","volume":"6","author":"Roberts","year":"2016","journal-title":"Int. J. Parasitol.: Drugs and Drug Resistance"},{"key":"10.1016\/j.ejmech.2019.05.043_bib187","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.ejmech.2015.02.038","article-title":"New heterocyclic hybrids of pyrazole and its bioisosteres: design, synthesis and biological evaluation as dual acting antimalarial-antileishmanial agents","volume":"94","author":"Bekhit","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.05.043_bib188","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.ejmech.2016.02.016","article-title":"Novel morpholinoquinoline nucleus clubbed with pyrazoline scaffolds: synthesis, antibacterial, antitubercular and antimalarial activities","volume":"112","author":"Karad","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.05.043_bib189","doi-asserted-by":"crossref","first-page":"5144","DOI":"10.1016\/j.bmc.2015.02.050","article-title":"Evaluation of spiropiperidine hydantoins as a novel class of antimalarial agents","volume":"23","author":"Meyers","year":"2015","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.05.043_bib190","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1016\/j.bmcl.2015.02.044","article-title":"Synthesis of 3-azabicyclo [3.2. 2] nonanes and their antiprotozoal activities","volume":"25","author":"Seebacher","year":"2015","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2019.05.043_bib191","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1021\/jm100938u","article-title":"A\u00a0chemotype that inhibits three unrelated pathogenic targets: the botulinum neurotoxin serotype A light chain, P. falciparum malaria, and the Ebola filovirus","volume":"54","author":"Opsenica","year":"2011","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2019.05.043_bib192","doi-asserted-by":"crossref","first-page":"5522","DOI":"10.1021\/acs.jmedchem.5b00515","article-title":"Protozoan parasite growth inhibitors discovered by cross-screening yield potent scaffolds for lead discovery","volume":"58","author":"Devine","year":"2015","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2019.05.043_bib193","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1016\/j.bmcl.2011.02.008","article-title":"Novel thiolactone\u2013isatin hybrids as potential antimalarial and antitubercular agents","volume":"21","author":"Hans","year":"2011","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2019.05.043_bib194","doi-asserted-by":"crossref","first-page":"4399","DOI":"10.1021\/jm200015a","article-title":"Optimization of 1, 2, 3, 4-tetrahydroacridin-9 (10H)-ones as antimalarials utilizing structure\u2013activity and structure\u2013property relationships","volume":"54","author":"Cross","year":"2011","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2019.05.043_bib195","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.ejmech.2012.12.010","article-title":"Synthesis, cytotoxicity and antiplasmodial activity of novel ent-kaurane derivatives","volume":"62","author":"Batista","year":"2013","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.05.043_bib196","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.ejmech.2013.04.030","article-title":"Evaluation of Jatropha isabelli natural products and their synthetic analogs as potential antimalarial therapeutic agents","volume":"65","author":"Hadi","year":"2013","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.05.043_bib197","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.ejmech.2012.12.013","article-title":"Asymmetric synthesis and anti-protozoal activity of the 8, 4\u2032-oxyneolignans virolin, surinamensin and analogues","volume":"60","author":"Rye","year":"2013","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.05.043_bib198","doi-asserted-by":"crossref","first-page":"10182","DOI":"10.1016\/j.bmc.2008.10.061","article-title":"New lycorine-type alkaloid from Lycoris traubii and evaluation of antitrypanosomal and antimalarial activities of lycorine derivatives","volume":"16","author":"Toriizuka","year":"2008","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.05.043_bib199","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.phytol.2010.06.004","article-title":"In\u00a0vitro antiprotozoal activity of alkaloids from Phaedranassa dubia (Amaryllidaceae)","volume":"3","author":"Osorio","year":"2010","journal-title":"Phytochem. Lett."},{"key":"10.1016\/j.ejmech.2019.05.043_bib200","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/j.ejmech.2013.03.018","article-title":"Preparation and antimalarial activity of semisynthetic lycorenine derivatives","volume":"63","author":"Cedr\u00f3n","year":"2013","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.05.043_bib201","doi-asserted-by":"crossref","first-page":"3088","DOI":"10.1016\/j.bmcl.2013.03.007","article-title":"New 11-oxocassane-type diterpenoids and a steroid glycoside from Caesalpinia volkensii stem bark and their antiplasmodial activities","volume":"23","author":"Ochieng","year":"2013","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2019.05.043_bib202","doi-asserted-by":"crossref","first-page":"5915","DOI":"10.1016\/j.bmcl.2013.08.077","article-title":"Chemical investigation of an antimalarial Chinese medicinal herb Picrorhiza scrophulariiflora","volume":"23","author":"Wang","year":"2013","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2019.05.043_bib203","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1016\/j.bmc.2013.01.037","article-title":"Probing functional diversity in pactamycin toward antibiotic, antitumor, and antiprotozoal activity","volume":"21","author":"Hanessian","year":"2013","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.05.043_bib204","doi-asserted-by":"crossref","first-page":"7591","DOI":"10.1016\/j.bmc.2013.10.038","article-title":"Bioactive compounds from Stuhlmannia moavi from the Madagascar dry forest","volume":"21","author":"Liu","year":"2013","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.05.043_bib205","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ejmech.2014.01.036","article-title":"Synthesis of febrifugine derivatives and development of an effective and safe tetrahydroquinazoline-type antimalarial","volume":"76","author":"Kikuchi","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.05.043_bib206","doi-asserted-by":"crossref","first-page":"3989","DOI":"10.1016\/j.tetlet.2014.05.056","article-title":"A\u00a0potent antimalarial trichothecene from hyphomycete species","volume":"55","author":"Waterman","year":"2014","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.ejmech.2019.05.043_bib207","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.bmc.2013.11.032","article-title":"Isolation of antiplasmodial anthraquinones from Kniphofia ensifolia, and synthesis and structure\u2013activity relationships of related compounds","volume":"22","author":"Dai","year":"2014","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.05.043_bib208","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1055\/s-2003-42778","article-title":"In\u00a0vitro antiplasmodial activity of abietane and totarane diterpenes isolated from Harpagophytum procumbens (Devil's Claw)","volume":"69","author":"Clarkson","year":"2003","journal-title":"Planta Med."},{"key":"10.1016\/j.ejmech.2019.05.043_bib209","doi-asserted-by":"crossref","first-page":"5234","DOI":"10.1016\/j.bmcl.2014.09.061","article-title":"Antimalarial activity of abietane ferruginol analogues possessing a phthalimide group","volume":"24","author":"Gonz\u00e1lez","year":"2014","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2019.05.043_bib210","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.ejmech.2015.08.022","article-title":"In\u00a0vivo evaluation of isolated triterpenes and semi-synthetic derivatives as antimalarial agents","volume":"102","author":"e Silva","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.05.043_bib211","doi-asserted-by":"crossref","first-page":"2631","DOI":"10.1016\/j.bmcl.2014.04.070","article-title":"Antiplasmodial activity of synthetic ellipticine derivatives and an isolated analog","volume":"24","author":"Montoia","year":"2014","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2019.05.043_bib212","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1186\/s12936-015-0999-2","article-title":"In\u00a0vitro and in\u00a0vivo anti-malarial activity of plants from the Brazilian Amazon","volume":"14","author":"Lima","year":"2015","journal-title":"Malar. J."},{"key":"10.1016\/j.ejmech.2019.05.043_bib213","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1021\/acs.jnatprod.5b01054","article-title":"Antimalarial oxoprotoberberine alkaloids from the leaves of Miliusa cuneata","volume":"79","author":"Promchai","year":"2016","journal-title":"J.\u00a0Nat. Prod."},{"key":"10.1016\/j.ejmech.2019.05.043_bib214","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1021\/acs.jnatprod.5b00874","article-title":"edssssssssxawqqqqqqqqqqqqqqqZZZZZZZZZZZdentification of compounds with efficacy against malaria parasites from common North American plants","volume":"79","author":"Cai","year":"2015","journal-title":"J.\u00a0Nat. Prod."},{"key":"10.1016\/j.ejmech.2019.05.043_bib215","doi-asserted-by":"crossref","first-page":"2932","DOI":"10.1021\/acs.jnatprod.5b00581","article-title":"Rotenoids, flavonoids, and chalcones from the root bark of Millettia usaramensis","volume":"79","author":"Deyou","year":"2015","journal-title":"J.\u00a0Nat. Prod."},{"key":"10.1016\/j.ejmech.2019.05.043_bib216","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1021\/np2004903","article-title":"Cytotoxic and antimalarial azaphilones from chaetomium longirostre","volume":"74","author":"Panthama","year":"2011","journal-title":"J.\u00a0Nat. Prod."},{"key":"10.1016\/j.ejmech.2019.05.043_bib217","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1021\/np300638f","article-title":"8, 8-dialkyldihydroberberines with potent antiprotozoal activity","volume":"76","author":"Endeshaw","year":"2012","journal-title":"J.\u00a0Nat. Prod."},{"key":"10.1016\/j.ejmech.2019.05.043_bib218","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1021\/acs.jnatprod.5b00354","article-title":"Antimalarial isocyano and isothiocyanato sesquiterpenes with tri-and bicyclic skeletons from the nudibranch phyllidia ocellata","volume":"79","author":"White","year":"2015","journal-title":"J.\u00a0Nat. Prod."},{"key":"10.1016\/j.ejmech.2019.05.043_bib219","doi-asserted-by":"crossref","first-page":"2364","DOI":"10.1021\/acs.jnatprod.5b00317","article-title":"Antimalarial and antiproliferative cassane diterpenes of Caesalpinia sappan","volume":"79","author":"Ma","year":"2015","journal-title":"J.\u00a0Nat. Prod."},{"key":"10.1016\/j.ejmech.2019.05.043_bib220","first-page":"1525","article-title":"Vaccine for malaria-prospects and promise","volume":"92","author":"Chauhan","year":"2007","journal-title":"Curr. Sci."},{"key":"10.1016\/j.ejmech.2019.05.043_bib221","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.cell.2006.02.011","article-title":"Malaria: new vaccine for old?","volume":"124","author":"Waters","year":"2006","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.ejmech.2019.05.043_bib222","first-page":"1","article-title":"Malaria vaccine development: recent Advances alongside the barriers","volume":"7","author":"Nega","year":"2016","journal-title":"J.\u00a0Bacteriol. Parasitol."},{"key":"10.1016\/j.ejmech.2019.05.043_bib223","author":"Ballo"},{"key":"10.1016\/j.ejmech.2019.05.043_bib224","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/s41541-017-0035-3","article-title":"Advacnes in malaria vaccine development: report from 2017 malaria vaccine development","volume":"2","author":"CoelhoJ","year":"2017","journal-title":"NPJ Vaccinces"},{"key":"10.1016\/j.ejmech.2019.05.043_bib225","series-title":"Anti-malaria Vaccine","author":"Cohen","year":"2007"},{"key":"10.1016\/j.ejmech.2019.05.043_bib226","series-title":"Vaccine","author":"Ballou","year":"2008"},{"key":"10.1016\/j.ejmech.2019.05.043_bib228","doi-asserted-by":"crossref","first-page":"4880","DOI":"10.1016\/j.vaccine.2010.05.033","article-title":"The RTS, S malaria vaccine","volume":"28","author":"Casares","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.ejmech.2019.05.043_bib229","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1097\/QCO.0000000000000002","article-title":"The whole parasite, pre-erythrocytic stage approach to malaria vaccine devFelopment: a review","volume":"26","author":"Epstein","year":"2013","journal-title":"Curr. Opin. Infect. Dis."},{"key":"10.1016\/j.ejmech.2019.05.043_bib230","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1086\/339409","article-title":"Protection of humans against malaria by immunization with radiation-attenuated Plasmodium falciparum sporozoites","volume":"185","author":"Hoffman","year":"2002","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.ejmech.2019.05.043_bib231","doi-asserted-by":"crossref","first-page":"7469","DOI":"10.1016\/j.vaccine.2015.09.057","article-title":"Whole organism blood stage vaccine against malaria","volume":"33","author":"Stanisic","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.ejmech.2019.05.043_bib232","doi-asserted-by":"crossref","first-page":"114","DOI":"10.4161\/hv.6.1.10394","article-title":"Whole parasite blood stage malaria vaccine: a convergence of evidence","volume":"6","author":"McCarthy","year":"2010","journal-title":"Human Vaccine"},{"key":"10.1016\/j.ejmech.2019.05.043_bib233","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1128\/IAI.73.4.2478-2485.2005","article-title":"Heterologous immunity in the absence of variant-specific antibodies after exposure to subpatent infection with blood-stage malaria","volume":"73","author":"Elliott","year":"2005","journal-title":"Infect. Immun."},{"key":"10.1016\/j.ejmech.2019.05.043_bib234","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1084\/jem.20011174","article-title":"The mechanism and significance of deletion of parasite-specific CD4\u00a0+ T cells in malaria infection","volume":"195","author":"Xu","year":"2002","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.ejmech.2019.05.043_bib235","doi-asserted-by":"crossref","first-page":"2967","DOI":"10.1172\/JCI39222","article-title":"Low doses of killed parasite in CpG elicit vigorous CD4\u00a0+ T cell responses against blood-stage malaria in mice","volume":"120","author":"Pinzon-Charry","year":"2010","journal-title":"J.\u00a0Clin.Invest."},{"key":"10.1016\/j.ejmech.2019.05.043_bib236","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.chom.2018.06.008","article-title":"Malaria vaccine: recent advances and new horizon","volume":"24","author":"Draper","year":"2018","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.ejmech.2019.05.043_bib237","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1016\/S0140-6736(13)62238-2","article-title":"Malaria vaccine technology road map","volume":"382","author":"Moorthy","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.ejmech.2019.05.043_bib238","series-title":"Plasmodium falciparum circumsporozoite vaccine gene optimization for soluble protein expression","author":"Dutta","year":"2011"},{"key":"10.1016\/j.ejmech.2019.05.043_bib239","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(15)60721-8","article-title":"Clinical trials Partnership,Efficacy and safety of RTS,S\/AS01 malaria vaccine with or without booster dose in infants and children in Africa:Final results of phase 3, individually randomized controlled trial","volume":"386","author":"RTS","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.ejmech.2019.05.043_bib240","series-title":"Malaria Vaccine","author":"Nussenzweig","year":"1984"},{"key":"10.1016\/j.ejmech.2019.05.043_bib241","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1056\/NEJMoa1505819","article-title":"Genetic diversity and protective efficacy of the RTS,S\/As01 malaria vaccine","volume":"373","author":"Neafsey","year":"2015","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ejmech.2019.05.043_bib242","series-title":"Hybrid Protein between CS from Plasmodium and HbsA","author":"Cohen","year":"1994"},{"key":"10.1016\/j.ejmech.2019.05.043_bib243","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1146\/annurev-med-022411-192402","article-title":"Vaccine for malaria: how close are we?","volume":"63","author":"Thera","year":"2012","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.ejmech.2019.05.043_bib244","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1016\/S0140-6736(04)17223-1","article-title":"Efficacy of the RTS, S\/AS02A vaccine against Plasmodium falciparum infection and disease in young African children: randomised controlled trial","volume":"364","author":"Alonso","year":"2004","journal-title":"The Lancet"},{"key":"10.1016\/j.ejmech.2019.05.043_bib245","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.1056\/NEJMoa0807381","article-title":"Efficacy of RTS, S\/AS01E vaccine against malaria in children 5 to 17 months of age","volume":"359","author":"Bejon","year":"2008","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ejmech.2019.05.043_bib247","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1016\/S1473-3099(15)00239-X","article-title":"Immunogenicity of the RTS,S\/As01 malaria vaccine and implications for duration of vaccine efficacy:secondary analysis of data from a phase 3 randomised controlled trial","volume":"15","author":"White","year":"2015","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.ejmech.2019.05.043_bib248","first-page":"E10438","article-title":"Structural basis for antibody recognition of the NANP repeats in Plasmodium falciparum circumsporozoite protein","volume":"114","author":"Oyen","year":"2017","journal-title":"Proc. Nathl. Acad. Sci. USA"},{"key":"10.1016\/j.ejmech.2019.05.043_bib249","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1038\/s41467-017-01924-3","article-title":"Molecular definition of multiple sites of antibody inhibition of malaria transmission-blocking vaccine antigen Pfs25","volume":"8","author":"Scally","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejmech.2019.05.043_bib250","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1073\/pnas.1621489114","article-title":"Systems analysis of protective immune responses to RTS,S malaria vaccination in humans","volume":"114","author":"Kazmin","year":"2017","journal-title":"Prof. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ejmech.2019.05.043_bib251","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1056\/NEJMoa1505819","article-title":"Genetic diversity and protective efficacy of the RTS,S\/As01 malaria vaccine","volume":"373","author":"Neafsey","year":"2015","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ejmech.2019.05.043_bib252","doi-asserted-by":"crossref","first-page":"79","DOI":"10.4161\/hv.6.1.10116","article-title":"Prime-boost vectored malaria vaccine: progress and prospects","volume":"6","author":"Hill","year":"2010","journal-title":"Human vaccine"},{"key":"10.1016\/j.ejmech.2019.05.043_bib253","first-page":"33","volume":"vol. 91","author":"World Health Organization","year":"2016"},{"key":"10.1016\/j.ejmech.2019.05.043_bib254","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/S1473-3099(17)30104-4","article-title":"Safety and efficacy of PfSPZ vaccine against Plasmodium falciparum via direct venous inoculation in healthy malaria-exposed adults in Mali: a randomized, double-blind phase 1 trial","volume":"17","author":"Sissoko","year":"2017","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.ejmech.2019.05.043_bib255","doi-asserted-by":"crossref","first-page":"7268","DOI":"10.4049\/jimmunol.0901957","article-title":"A\u00a0nonadjuvanted polypeptide nanoparticle vaccine confers long-lasting protection against rodent malaria","volume":"183","author":"Kaba","year":"2009","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.ejmech.2019.05.043_bib256","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0024398","article-title":"Protection from experimental cerebral malaria with a single dose of radiation-attenuated, blood-stagePlasmodium berghei parasites","volume":"6","author":"Gerald","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.ejmech.2019.05.043_bib257","doi-asserted-by":"crossref","first-page":"5870","DOI":"10.4049\/jimmunol.0900302","article-title":"Genetically attenuated parasite vaccine induce contact-dependent CD8+ T cell killing of Plasmodium yoelii liver stage-infected hepatocytes","volume":"183","author":"Trimnell","year":"2009","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.ejmech.2019.05.043_bib258","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1093\/infdis\/jis645","article-title":"Radiation-induced cellular and molecular alterations in asexual intraerythrocyticPlasmodium falciparum","volume":"207","author":"Oakley","year":"2012","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.ejmech.2019.05.043_bib259","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1097\/QCO.0000000000000002","article-title":"The whole parasite, pre-erythrocytic stage approach to malaria vaccine development: a review","volume":"26","author":"Epstein","year":"2013","journal-title":"Curr. Opin. Infect. Dis."},{"key":"10.1016\/j.ejmech.2019.05.043_bib260","author":"Hoffman"},{"key":"10.1016\/j.ejmech.2019.05.043_bib261","article-title":"Protection against Plasmodium falciparum malaria by PfSPZ vaccine","volume":"2","author":"Epstein","year":"2017","journal-title":"J.C.I. Insight"},{"key":"10.1016\/j.ejmech.2019.05.043_bib262","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1126\/science.1241800","article-title":"Protection against malaria by intravenous immunization with a nonreplicating sporozoite vaccine","volume":"341","author":"Seder","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2019.05.043_bib263","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1126\/science.1211548","article-title":"Live attenuated malaria vaccine designed to protect through hepatic CD8+ T cell immunity","volume":"334","author":"Epstein","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2019.05.043_bib264","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1186\/s12916-017-0923-4","article-title":"Modest heterologous protection after Plasmodium falciparum sporozoite immunization: a double-blind randomized controlled clinical trial","volume":"15","author":"Walk","year":"2017","journal-title":"BMC Med."},{"key":"10.1016\/j.ejmech.2019.05.043_bib265","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/nature21060","article-title":"Sterile protection against human malaria by chemoattenuated PfSPZ vaccine","volume":"542","author":"Mordmuller","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2019.05.043_bib266","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1007\/s12026-014-8525-0","article-title":"Correlates of protective immunity following whole sporozoite vaccination against malaria","volume":"59","author":"Doll","year":"2014","journal-title":"Immunol. Res."},{"key":"10.1016\/j.ejmech.2019.05.043_bib267","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/j.immuni.2016.08.011","article-title":"Liver-resident memory CD8+ T cells form a front-line defense against malaria liver-stage infection","volume":"45","author":"Fernandez-Ruiz","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.ejmech.2019.05.043_bib268","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1038\/nm.4110","article-title":"Protection against malaria at 1 year and immune correlates following PfSPZ vaccination","volume":"22","author":"Ishizuka","year":"2016","journal-title":"Nat. Med."},{"key":"10.1016\/j.ejmech.2019.05.043_bib269","doi-asserted-by":"crossref","first-page":"3781","DOI":"10.4049\/jimmunol.1700314","article-title":"\u03b3 \u03b4 T cells are required for the induction of sterile immunity during irradiated sporozoite vaccinations","volume":"199","author":"Zaidi","year":"2017","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.ejmech.2019.05.043_bib270","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1086\/526788","article-title":"Potent antimalarial and transmission-blocking activities of centanamycin, a novel DNA-binding agent","volume":"197","author":"Yanow","year":"2008","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.ejmech.2019.05.043_bib271","doi-asserted-by":"crossref","first-page":"4880","DOI":"10.1016\/j.vaccine.2008.07.017","article-title":"Chemically attenuated Plasmodium sporozoites induce specific immune responses, sterile immunity and cross-protection against heterologous challenge","volume":"26","author":"Purcell","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.ejmech.2019.05.043_bib272","doi-asserted-by":"crossref","first-page":"3353","DOI":"10.1172\/JCI66634","article-title":"Cross-species malaria immunity induced by chemically attenuated parasites","volume":"123","author":"Good","year":"2013","journal-title":"J.\u00a0Clin.Invest."},{"key":"10.1016\/j.ejmech.2019.05.043_bib273","doi-asserted-by":"crossref","first-page":"13004","DOI":"10.1073\/pnas.0906387106","article-title":"Preerythrocytic, live-attenuated Plasmodium falciparum vaccine candidates by design","volume":"106","author":"VanBuskirk","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.ejmech.2019.05.043_bib274","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1038\/nm.1867","article-title":"Attenuated Plasmodium yoelii lacking purine nucleoside phosphorylase confer protective immunity","volume":"14","author":"Ting","year":"2008","journal-title":"Nat. Med."},{"key":"10.1016\/j.ejmech.2019.05.043_bib275","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.ijpara.2006.11.008","article-title":"Effects on growth, hemoglobin metabolism and paralogous gene expression resulting from disruption of genes encoding the digestive vacuole plasmepsins of Plasmodium falciparum","volume":"37","author":"Bonilla","year":"2007","journal-title":"Int. J. Parasitol."},{"key":"10.1016\/j.ejmech.2019.05.043_bib276","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/srep00039","article-title":"Disruption of plasmepsin-4 and merozoites surface protein-7 genes in Plasmodium berghei induces combined virulence-attenuated phenotype","volume":"1","author":"Spaccapelo","year":"2011","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2019.05.043_bib277","doi-asserted-by":"crossref","first-page":"3633","DOI":"10.1007\/s00018-014-1614-3","article-title":"Surface antigens of Plasmodium falciparum-infected erythrocytes as immune targets and malaria vaccine candidates","volume":"71","author":"Chan","year":"2014","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.ejmech.2019.05.043_bib278","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1182\/blood-2005-11-4624","article-title":"The role of KAHRP domains in knob formation and cytoadherence of P falciparum-infected human erythrocytes","volume":"108","author":"Rug","year":"2006","journal-title":"Blood"},{"issue":"371","key":"10.1016\/j.ejmech.2019.05.043_bib279","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aad9099","article-title":"Complete attenuation of genetically engineered Plasmodium Falciparum sprorozoites in human subjects","volume":"9","author":"Kublin","year":"2017","journal-title":"Sci. Trans. Med."},{"key":"10.1016\/j.ejmech.2019.05.043_bib280","doi-asserted-by":"crossref","first-page":"4975","DOI":"10.1016\/j.vaccine.2013.08.007","article-title":"First-in-human evaluation of genetically attenuated Plasmodium flaciparum sporozoites administered by bite of Anopheles mosquitoes to adult volunteers","volume":"31","author":"Spring","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.ejmech.2019.05.043_bib281","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1004855","article-title":"Mechanisms of stage-transcending protection following immunization of mice with late liver stage-arresting genetically attenuated malaria parasites","volume":"11","author":"Sack","year":"2015","journal-title":"PLos Patho"},{"key":"10.1016\/j.ejmech.2019.05.043_bib282","doi-asserted-by":"crossref","first-page":"7444","DOI":"10.1016\/j.vaccine.2015.09.094","article-title":"Progress with viral vectored malaria vaccine: a multi-stage approach involving \u201cunnatural immunity\u201d","volume":"33","author":"Ewer","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.ejmech.2019.05.043_bib283","doi-asserted-by":"crossref","first-page":"2836","DOI":"10.1038\/ncomms3836","article-title":"Protective CD8+ T-cell immunity to human malaria induced by chimpanzee adenovirus-MVA immunization","volume":"4","author":"Ewer","year":"2013","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejmech.2019.05.043_bib284","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1038\/mt.2012.223","article-title":"Chad63-MVA-vectored blood-stage malaria vaccine targeting MSP1 and AMA1: assessment of efficacy against mosquito bite challenge in humans","volume":"20","author":"Sheehy","year":"2012","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ejmech.2019.05.043_bib285","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1093\/infdis\/jiu579","article-title":"Evaluation of the efficacy of Chad63-MVA vectored vaccine expressing circumsporozoite protein and ME-TRAP against controlled human malaria infection in malaria-na\u00efve individuals","volume":"211","author":"Hodgson","year":"2015","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.ejmech.2019.05.043_bib286","first-page":"69","article-title":"A\u00a0sufficient role of MHC class I molecules on hepatocytes in anti-plasmodial activity of CD8+ T cells in\u00a0vivo","volume":"6","author":"Huang","year":"2015","journal-title":"Front. Microbial"},{"key":"10.1016\/j.ejmech.2019.05.043_bib287","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/S0140-6736(03)15267-1","article-title":"Malaria vaccine developments","volume":"363","author":"Moorthy","year":"2004","journal-title":"The Lancet"},{"key":"10.1016\/j.ejmech.2019.05.043_bib288","doi-asserted-by":"crossref","first-page":"7292","DOI":"10.1016\/j.vaccine.2009.10.087","article-title":"A\u00a0randomized and controlled Phase 1 study of the safety and immunogenicity of the AMA1-C1\/Alhydrogel\u00ae+ CPG 7909 vaccine forPlasmodium falciparum malaria in semi-immune Malian adults","volume":"27","author":"Sagara","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.ejmech.2019.05.043_bib289","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1128\/CVI.00082-10","article-title":"Safety and immunogenicity of a recombinant nonglycosylated erythrocyte binding antigen 175 Region II malaria vaccine in healthy adults living in an area where malaria is not endemic","volume":"17","author":"El Sahly","year":"2010","journal-title":"Clin. Vaccine Immunol."},{"key":"10.1016\/j.ejmech.2019.05.043_bib290","first-page":"6862","volume":"vol. 27","author":"Esen","year":"2009"},{"key":"10.1016\/j.ejmech.2019.05.043_bib291","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0004708","article-title":"Blood stage malaria vaccine eliciting high antigen-specific antibody concentrations confers no protection to young children in Western Kenya","volume":"4","author":"Ogutu","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.ejmech.2019.05.043_bib292","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1086\/339342","article-title":"A\u00a0recombinant blood-stage malaria vaccine reducesPlasmodium falciparum density and exerts selective pressure on parasite populations in a phase 1-2b trial in Papua New Guinea","volume":"185","author":"Genton","year":"2002","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.ejmech.2019.05.043_bib293","doi-asserted-by":"crossref","first-page":"8017","DOI":"10.1128\/IAI.73.12.8017-8026.2005","article-title":"Phase I malaria vaccine trial with a long synthetic peptide derived from the merozoite surface protein 3 antigen","volume":"73","author":"Audran","year":"2005","journal-title":"Infect. Immun."},{"key":"10.1016\/j.ejmech.2019.05.043_bib294","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1093\/infdis\/jit185","article-title":"The malaria vaccine candidate GMZ2 elicits functional antibodies in individuals from malaria endemic and non-endemic areas","volume":"208","author":"Jepsen","year":"2013","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.ejmech.2019.05.043_bib295","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.parint.2010.05.002","article-title":"Evidences of protection against blood-stage infection ofPlasmodium falciparum by the novel protein vaccine SE36","volume":"59","author":"Horii","year":"2010","journal-title":"Parasitol. Int."},{"key":"10.1016\/j.ejmech.2019.05.043_bib296","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0064073","article-title":"Phase 1b randomized trial and follow-up study in Uganda of the blood-stage malaria vaccine candidate BK-SE36","volume":"8","author":"Palacpac","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ejmech.2019.05.043_bib297","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1111\/j.1365-3024.2009.01138.x","article-title":"Genetic diversity and malaria vaccine design, testing and efficacy: preventing and overcoming \u2018vaccine resistant malaria","volume":"31","author":"Takala","year":"2009","journal-title":"Parasite Immunol."},{"key":"10.1016\/j.ejmech.2019.05.043_bib298","doi-asserted-by":"crossref","first-page":"4168","DOI":"10.1172\/JCI44423","article-title":"Advances and challenges in malaria vaccine development","volume":"120","author":"Crompton","year":"2010","journal-title":"JCI (J. Clin. Investig.)"},{"key":"10.1016\/j.ejmech.2019.05.043_bib299","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.pt.2013.10.001","article-title":"Escaping the immune system: how the malaria parasite makes vaccine development a challenge","volume":"29","author":"Stanisic","year":"2013","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.ejmech.2019.05.043_bib300","doi-asserted-by":"crossref","first-page":"6864","DOI":"10.1016\/j.vaccine.2008.09.081","article-title":"A\u00a0phase 1 trial of PfCP2. 9: an AMA1\/MSP1 chimeric recombinant protein vaccine for Plasmodium falciparum malaria","volume":"26","author":"Malkin","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.ejmech.2019.05.043_bib301","doi-asserted-by":"crossref","first-page":"e8797","DOI":"10.1371\/journal.pone.0008787","article-title":"Phase 1 trial of thePlasmodium falciparum blood stage vaccine MSP142-C1\/Alhydrogel with and without CPG 7909 in malaria na\u00efve adults","volume":"5","author":"Ellis","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.ejmech.2019.05.043_bib302","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.vaccine.2012.10.106","article-title":"A\u00a0full-length recombinant Plasmodium falciparum PfRH 5 protein induces inhibitory antibodies that are effective across common PfRH 5 genetic variants","volume":"31","author":"Bustamante","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.ejmech.2019.05.043_bib303","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1038\/ncomms1615","article-title":"The blood-stage malaria antigen PfRH 5 is susceptible to vaccine-inducible cross-strain neutralizing antibody","volume":"2","author":"Douglas","year":"2011","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejmech.2019.05.043_bib304","doi-asserted-by":"crossref","first-page":"4290","DOI":"10.1128\/IAI.00690-13","article-title":"RALP1 is a rhoptry neck erythrocyte-binding protein ofPlasmodium falciparum merozoites and a potential blood-stage vaccine candidate antigen","volume":"81","author":"Ito","year":"2013","journal-title":"Infect. Immun."},{"key":"10.1016\/j.ejmech.2019.05.043_bib305","doi-asserted-by":"crossref","DOI":"10.1128\/IAI.00062-17","article-title":"Chemical attenuation in the developmemt ofa whole-organism malaria vaccine","volume":"85","author":"Raja","year":"2017","journal-title":"Infect. Immun."},{"key":"10.1016\/j.ejmech.2019.05.043_bib306","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1080\/14760584.2017.1322512","article-title":"Pre-clinical and clinical development of the first placental malaria vaccine","volume":"16","author":"Pegrson","year":"2017","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.ejmech.2019.05.043_bib307","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2013\/282913","article-title":"Malaria vaccine adjuvants: latest update and challenges in preclinical and clinical research","author":"Mata","year":"2013","journal-title":"BioMed Res. Int."},{"key":"10.1016\/j.ejmech.2019.05.043_bib308","doi-asserted-by":"crossref","first-page":"479","DOI":"10.2174\/1566524011313040002","article-title":"Single-dose microparticle delivery of a malaria transmission-blocking vaccine elicits a long-lasting functional antibody response","volume":"13","author":"Dinglasan","year":"2013","journal-title":"Curr. Mol. Med."},{"key":"10.1016\/j.ejmech.2019.05.043_bib309","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1101\/gad.1656508","article-title":"The conserved plant sterility gene HAP2 functions after attachment of fusogenic membranes in Chlamydomonas and Plasmodium gametes","volume":"22","author":"Liu","year":"2008","journal-title":"Genes Dev."},{"key":"10.1016\/j.ejmech.2019.05.043_bib310","doi-asserted-by":"crossref","first-page":"5187","DOI":"10.1016\/j.vaccine.2009.06.069","article-title":"Plasmodium berghei HAP2 induces strong malaria transmission-blocking immunity in\u00a0vivo and in\u00a0vitro","volume":"27","author":"Blagborough","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.ejmech.2019.05.043_bib311","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000398","article-title":"A\u00a0research agenda for malaria eradication: vaccine","volume":"8","author":"The malERA Consultative Group on Vaccine","year":"2011","journal-title":"PLoS Med."},{"key":"10.1016\/j.ejmech.2019.05.043_bib312","doi-asserted-by":"crossref","first-page":"223","DOI":"10.2174\/156652406776055140","article-title":"Sexual-stage antibody responses to P. falciparum in endemic populations","volume":"6","author":"Bousema","year":"2006","journal-title":"Curr. Mol. Med."},{"key":"10.1016\/j.ejmech.2019.05.043_bib313","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1017\/S0031182008000280","article-title":"Efficacy model for mosquito stage transmission blocking vaccine for malaria","volume":"135","author":"Saul","year":"2008","journal-title":"Parasitology"},{"key":"10.1016\/j.ejmech.2019.05.043_bib314","doi-asserted-by":"crossref","first-page":"7375","DOI":"10.1128\/IAI.73.11.7375-7380.2005","article-title":"Nasal immunization with a malaria transmission-blocking vaccine candidate, Pfs25, induces complete protective immunity in mice against field isolates of Plasmodium falciparum","volume":"73","author":"Arakawa","year":"2005","journal-title":"Infect. Immun."},{"key":"10.1016\/j.ejmech.2019.05.043_bib315","doi-asserted-by":"crossref","first-page":"32","DOI":"10.4269\/ajtmh.2005.73.32","article-title":"Induction of transmission-blocking immunity in Aotus monkeys by vaccination with a Plasmodium vivax clinical grade PVS25 recombinant protein","volume":"73","author":"Arevalo-Herrera","year":"2005","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.ejmech.2019.05.043_bib316","doi-asserted-by":"crossref","first-page":"6618","DOI":"10.1128\/IAI.68.12.6618-6623.2000","article-title":"Antibodies to malaria vaccine candidates Pvs25 and Pvs28 completely block the ability ofPlasmodium vivax to infect mosquitoes","volume":"68","author":"Hisaeda","year":"2000","journal-title":"Infect. Immun."},{"key":"10.1016\/j.ejmech.2019.05.043_bib317","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0006352","article-title":"A\u00a0potent malaria transmission blocking vaccine based on codon harmonized full length Pfs48\/45 expressed in Escherichia coli","volume":"4","author":"Chowdhury","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.ejmech.2019.05.043_bib318","doi-asserted-by":"crossref","first-page":"2806","DOI":"10.1098\/rstb.2011.0091","article-title":"Vaccine against malaria","volume":"366","author":"Hill","year":"2011","journal-title":"Philos. Trans. R. Soc. Lond. B Biol. Sci."},{"key":"10.1016\/j.ejmech.2019.05.043_bib319","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/73062","article-title":"Malaria transmission-blocking vaccine\u2014how can their development be supported?","volume":"6","author":"Carter","year":"2000","journal-title":"Nat. Med."},{"key":"10.1016\/j.ejmech.2019.05.043_bib320","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1073\/pnas.0913374107","article-title":"A\u00a0bicomponent Plasmodium falciparum investigational vaccine composed of protein-peptide conjugates","volume":"107","author":"Kubler-Kielb","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.ejmech.2019.05.043_bib321","doi-asserted-by":"crossref","first-page":"13461","DOI":"10.1073\/pnas.0702239104","article-title":"Disruption of Plasmodium falciparum development by antibodies against a conserved mosquito midgut antigen","volume":"104","author":"Dinglasan","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.ejmech.2019.05.043_bib322","unstructured":"WHO, https:\/\/www.who.int\/vaccine_research\/links\/Rainbow\/en\/index.html . (Accessed Jan, 2018)."},{"key":"10.1016\/j.ejmech.2019.05.043_bib323","doi-asserted-by":"crossref","first-page":"5115","DOI":"10.1016\/j.vaccine.2007.01.085","article-title":"Measurement of malaria vaccine efficacy in phase III trials: report of a WHO consultation","volume":"25","author":"Moorthy","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.ejmech.2019.05.043_bib324","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1073\/pnas.0307158101","article-title":"A\u00a0Plasmodium falciparum candidate vaccine based on a six-antigen polyprotein encoded by recombinant poxviruses","volume":"101","author":"Prieur","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.ejmech.2019.05.043_bib325","doi-asserted-by":"crossref","first-page":"5819","DOI":"10.1128\/IAI.00828-07","article-title":"Combination of protein and viral vaccine induces potent cellular and humoral immune responses and enhanced protection from murine malaria challenge","volume":"75","author":"Hutchings","year":"2007","journal-title":"Infect. Immun."},{"key":"10.1016\/j.ejmech.2019.05.043_bib326","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1038\/nature01097","article-title":"Genome sequence of the human malaria parasite Plasmodium falciparum","volume":"419","author":"Gardner","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2019.05.043_bib327","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1038\/nature01099","article-title":"Genome sequence and comparative analysis of the model rodent malaria parasite Plasmodium yoelii yoelii","volume":"419","author":"Carlton","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2019.05.043_bib328","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1126\/science.1103717","article-title":"A\u00a0comprehensive survey of the Plasmodium life cycle by genomic, transcriptomic, and proteomic analyses","volume":"307","author":"Hall","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2019.05.043_bib329","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1038\/nature07327","article-title":"Comparative genomics of the neglected human malaria parasite Plasmodium vivax","volume":"455","author":"Carlton","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2019.05.043_bib330","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1038\/nature07306","article-title":"The genome of the simian and human malaria parasite Plasmodium knowlesi","volume":"455","author":"Pain","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2019.05.043_bib331","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1126\/science.1076181","article-title":"The genome sequence of the malaria mosquito anopheles gambiae","volume":"298","author":"Holt","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2019.05.043_bib332","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/nchem.1830","article-title":"Validation of N-myristoyltransferase as an antimalarial drug target using an integrated chemical biology approach","volume":"6","author":"Wright","year":"2014","journal-title":"Nat. Chem."},{"key":"10.1016\/j.ejmech.2019.05.043_bib333","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.chom.2012.12.006","article-title":"Na+ regulation in the malaria parasite Plasmodium falciparum involves the cation ATPase PfATP4 and is a target of the spiroindolone antimalarials","volume":"13","author":"Spillman","year":"2013","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.ejmech.2019.05.043_bib334","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.chom.2012.04.015","article-title":"Selective and specific inhibition of the Plasmodium falciparum lysyl-tRNA synthetase by the fungal secondary metabolite cladosporin","volume":"11","author":"Hoepfner","year":"2012","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.ejmech.2019.05.043_bib335","doi-asserted-by":"crossref","first-page":"59","DOI":"10.2217\/pgs.10.165","article-title":"How can we identify parasite genes that underlie antimalarial drug resistance?","volume":"12","author":"Anderson","year":"2011","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.ejmech.2019.05.043_bib336","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1038\/nmeth.2143","article-title":"Site-specific genome editing in Plasmodium falciparum using engineered zinc-finger nucleases","volume":"9","author":"Straimer","year":"2012","journal-title":"Nat. Methods"},{"key":"10.1016\/j.ejmech.2019.05.043_bib337","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1038\/nbt.2925","article-title":"Genome editing in the human malaria parasite Plasmodium falciparum using the CRISPR-Cas9 system","volume":"32","author":"Ghorbal","year":"2014","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ejmech.2019.05.043_bib338","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1038\/nmeth.3063","article-title":"Efficient CRISPR-Cas9-mediated genome editing in Plasmodium falciparum","volume":"11","author":"Wagner","year":"2014","journal-title":"Nat. Methods"},{"key":"10.1016\/j.ejmech.2019.05.043_bib339","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/nature12782","article-title":"Targeting Plasmodium PI (4) K to eliminate malaria","volume":"504","author":"McNamara","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2019.05.043_bib340","first-page":"657","article-title":"Development of humanized mouse models to study human malaria parasite infection","volume":"7","author":"Vaughan","year":"2012","journal-title":"Futuremicrobial"},{"key":"10.1016\/j.ejmech.2019.05.043_bib341","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1111\/cmi.12277","article-title":"Of men in mice: the success and promise of humanized mouse models for human malaria parasite infections","volume":"16","author":"Kaushansky","year":"2014","journal-title":"Cell. Microbial."},{"key":"10.1016\/j.ejmech.2019.05.043_bib342","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1038\/nrmicro1529","article-title":"The silent path to thousands of merozoites: the Plasmodium liver stage","volume":"4","author":"Prud\u00eancio","year":"2006","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.ejmech.2019.05.043_bib343","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1000825","article-title":"Exoerythrocytic Plasmodium parasites secrete a cysteine protease inhibitor involved in sporozoite invasion and capable of blocking cell death of host hepatocytes","volume":"6","author":"Rennenberg","year":"2010","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.ejmech.2019.05.043_bib344","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1146\/annurev.micro.091208.073403","article-title":"Malaria parasite development in the mosquito and infection of the mammalian host","volume":"63","author":"Aly","year":"2009","journal-title":"Annu. Rev. Microbiol."},{"key":"10.1016\/j.ejmech.2019.05.043_bib345","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s00251-016-0918-x","article-title":"HLA class I molecular variation and peptide-binding properties suggest a model of joint divergent asymmetric selection","volume":"68","author":"Buhler","year":"2016","journal-title":"Immunogenetics"},{"key":"10.1016\/j.ejmech.2019.05.043_bib346","first-page":"101","article-title":"Nepalese populations show no association between the distribution of malaria and protective alleles","volume":"2","author":"Caetano","year":"2006","journal-title":"J.\u00a0Mol.Genetic Med."},{"key":"10.1016\/j.ejmech.2019.05.043_bib347","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1017\/S0030605311001670","article-title":"Past, present and future conservation of the greater one-horned rhinoceros Rhinoceros unicornis in Nepal","volume":"47","author":"Thapa","year":"2013","journal-title":"Oryx"},{"key":"10.1016\/j.ejmech.2019.05.043_bib348","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1182\/blood.V100.4.1172.h81602001172_1172_1176","article-title":"A\u00a0balanced polymorphism protective against high parasitemias and thus severe P falciparum malaria","volume":"100","author":"Chotivanich","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.ejmech.2019.05.043_bib349","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1038\/383522a0","article-title":"High incidence of malaria in \u03b1-thalassaemic children","volume":"383","author":"Williams","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2019.05.043_bib350","doi-asserted-by":"crossref","first-page":"14736","DOI":"10.1073\/pnas.94.26.14736","article-title":"\u03b1+-Thalassemia protects children against disease caused by other infections as well as malaria","volume":"94","author":"Allen","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.ejmech.2019.05.043_bib351","doi-asserted-by":"crossref","first-page":"39","DOI":"10.4103\/0971-6866.34704","article-title":"Complement receptor 1 and the molecular pathogenesis of malaria","volume":"13","author":"Gandhi","year":"2007","journal-title":"Indian J. Hum. Genet."},{"key":"10.1016\/j.ejmech.2019.05.043_bib352","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0140-6736(05)78273-8","article-title":"Polymorphism in promoter region of inducible nitric oxide synthase gene and protection against malaria","volume":"351","author":"Kun","year":"1998","journal-title":"The Lancet"},{"key":"10.1016\/j.ejmech.2019.05.043_bib353","doi-asserted-by":"crossref","first-page":"55","DOI":"10.5581\/v33n1a16","article-title":"Blood Group System and the malaria adaptation process in humans","volume":"33","author":"Carvalho","year":"2011","journal-title":"Rev. Bras. Hematol. Hemoter."},{"key":"10.1016\/j.ejmech.2019.05.043_bib354","doi-asserted-by":"crossref","first-page":"3364","DOI":"10.1182\/blood-2003-11-3820","article-title":"Enhanced phagocytosis of ring-parasitized mutant erythrocytes: a common mechanism that may explain protection against falciparum malaria in sickle trait and beta-thalassemia trait","volume":"104","author":"Ayi","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.ejmech.2019.05.043_bib355","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/1756-3305-5-69","article-title":"A\u00a0global map of dominant malaria vectors","volume":"5","author":"Sinka","year":"2012","journal-title":"Parasites Vectors"},{"key":"10.1016\/j.ejmech.2019.05.043_bib356","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/S0140-6736(13)60024-0","article-title":"Malaria","volume":"383","author":"White","year":"2014","journal-title":"The Lancet"},{"key":"10.1016\/j.ejmech.2019.05.043_bib357","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1126\/science.1251449","article-title":"Measuring the path toward malaria elimination","volume":"344","author":"Churcher","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2019.05.043_bib358","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001619","article-title":"The impact of pyrethroid resistance on the efficacy of insecticide-treated bed nets against African anopheline mosquitoes: systematic review and meta-analysis","volume":"11","author":"Strode","year":"2014","journal-title":"PLoS Med."},{"key":"10.1016\/j.ejmech.2019.05.043_bib359","doi-asserted-by":"crossref","first-page":"11","DOI":"10.4137\/HPD.S16590","article-title":"Malaria: control, elimination, and eradication","volume":"8","author":"Ojurongbe","year":"2016","journal-title":"Hum. Parasit. Dis."},{"issue":"4","key":"10.1016\/j.ejmech.2019.05.043_bib360","first-page":"1","article-title":"Indoor residual spraying for preventing malaria","volume":"14","author":"Pluess","year":"2010","journal-title":"Cochrane Database Syst. Rev."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523419304532?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523419304532?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T14:06:46Z","timestamp":1759327606000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523419304532"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":357,"alternative-id":["S0223523419304532"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2019.05.043","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"New dimensions in the field of antimalarial research against malaria resurgence","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2019.05.043","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"111353"}}